The Texas heart attack prevention bill mandating coverage for CAD screening tests

Journal of Nuclear Cardiology

Volumn 16, Issue 5, 2009, Pages 681-682

  Beller, George A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL TRIAL; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EDITORIAL; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE DISTRIBUTION; HEALTH CARE POLICY; HEALTH INSURANCE; HEART INFARCTION; HEART INFARCTION PREVENTION; HUMAN; LAW ENFORCEMENT; LIFESTYLE MODIFICATION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; UNITED STATES;

CORONARY ARTERY DISEASE; GOVERNMENT REGULATION; HEART FAILURE; HUMANS; INSURANCE COVERAGE; MASS SCREENING; TEXAS;

EID: 70349844373     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-009-9139-0     Document Type: Editorial

References (11)

1. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient - Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006;98:2H-15H.
2. Kaul P, Douglas PS. Atherosclerosis imaging: Prognostically useful or merely more of what we know? Circ Cardiovasc Imaging 2009;2:150-60.
3. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210-5. Erratum in: JAMA 2004 Feb 4;291:563.
4. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 2006;184:201-6.
5. Anand DV, Lim E, Hopkins D, Corder R, Shaw LJ, Sharp P, et al. Risk stratification in uncomplicated type 2 diabetes: Prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 2006;27:713-21.
6. Elkeles RS, Godsland IF, Feher MD, Rubens MB, Roughton M, Nugara F, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: The PREDICT study. Eur Heart J 2008;29:2244-51.
7. Sarwar A, Shaw LJ, Shapiro MD, Blankstein R, Hoffman U, Cury RC, et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2009;2:675-88.
8. Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging 2009;2:692-700.
9. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term prognosis associated with coronary calcification: Observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-70.
10. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336-45.
11. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 2007;115:402-26.